Cellebrite DI (CLBT) Receivables (2020 - 2025)

Cellebrite DI's Receivables history runs 6 years deep, the most recent figure standing at $78.6 million for Q4 2025.

• In Q4 2025, Receivables fell 4.44% year-over-year to $78.6 million; the TTM figure through Dec 2025 stood at $78.6 million (down 4.44% YoY), while the FY2025 annual figure was $78.6 million, down 4.44% from the prior year.
• Receivables was $78.6 million for Q4 2025 at Cellebrite DI, down from $82.2 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $139.8 million in Q4 2021 to a low of $78.6 million in Q4 2025.
• Historically, Receivables has averaged $94.4 million across 5 years, with a median of $82.2 million in 2024.
• The sharpest annual moves came in 2021 and 2022: Receivables surged 39.45% in 2021, then tumbled 41.58% in 2022.
• A 5-year view of Receivables shows it stood at $139.8 million in 2021, then sank by 41.58% to $81.6 million in 2022, then increased by 9.64% to $89.5 million in 2023, then retreated by 8.13% to $82.2 million in 2024, then slipped by 4.44% to $78.6 million in 2025.
• The last three Receivables figures came in at $78.6 million (Q4 2025), $82.2 million (Q4 2024), and $89.5 million (Q4 2023), per Business Quant data.